Journal: Frontiers in Bioengineering and Biotechnology
Article Title: Hydrogen improves the efficacy of tetrandrine in the treatment of silicosis by inhibiting vascular endothelial mesenchymal transition caused by oxidative stress
doi: 10.3389/fbioe.2025.1668524
Figure Lengend Snippet: Inhibiting oxidative stress can improve the concentration of tetrandrine in lung tissue in mice with silicosis. (A,B) , Changes in the ROS levels in the lung tissues (n = 3). Scale bar, 20 μm, ROS: reactive oxygen species, DAPI: 4′,6-Diamidino-2-phenylindole dihydrochloride, Merge: ROS combines with the cell nucleus; (C) , Western blotting of Keap1, Nrf2, Pink1, Parkin, Bcl-2 and Bax expression in the lung tissues (n = 3); (D,E) , Semi-quantitative of the expression of Keap1 and Nrf2 in the lung tissues of different mouse groups (n = 3); (F) , Mitochondrial injury observed under transmission electron microscopy (TEM) (n = 3). Scale bar, 2.0 (×4.0k) and 1.0 (×8.0k) μm; (G–J) , Semi-quantitative of the expression of Pink1, Parkin, Bcl-2 and Bax in the lung tissues of different mouse groups (n = 3); (K,L) , Immunofluorescence and semi-quantitative of the expression of the endothelial to mesenchymal transition (EndMT)-related proteins platelet endothelial cell adhesion molecule-1 (CD31) and alfa-smooth muscle actin (α–SMA) in the lung tissues of different mouse groups (n = 3). Scale bar, 10 μm and 2 μm; (M) , The concentration of tetrandrine in lung tissue was detected by LC/MS-MS (n = 3 biologically independent experiments). a P < 0.05; aa P < 0.01; aaa P < 0.001 vs. the control group. b P < 0.05; bb P < 0.01 vs. the model group. Data are expressed as mean ± SD.
Article Snippet: The membranes were incubated with the primary antibodies, namely, Pink1 (1:1000 dilution, Proteintech, United States, 23274-1-AP), LC3 (1:1000 dilution, Cell Signaling Technology, United States, 12741T), sequestosome 1 (SQSTM1/p62) (1:1000 dilution, Cell Signaling Technology, United States, 5114T), Parkin (1:2000 dilution, Proteintech, United States, 14060-1-AP), Kelch-like ECH-associated protein 1 (Keap1) (1:1000 dilution, Proteintech, United States, 60027-1-Ig), nuclear factor E2-related factor 2 (Nrf2) (1:2000 dilution, Proteintech, United States, 16396-1-AP), B- cell lymphoma - 2 (Bcl-2) (1:2000 dilution, Proteintech, United States, 26593-1-AP), Bcl - 2-associated X protein (Bax) (1:5000 dilution, Proteintech, United States, 50599-2-Ig), Cytochrome C (Cyto C) (1:5000, Proteintech, United States, 10993-1-AP), Caspase 3 (1:1000 dilution, Proteintech, United States, 19677-1-AP) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1:500000 dilution, Proteintech, United States, 60004-1-Ig).
Techniques: Concentration Assay, Western Blot, Expressing, Transmission Assay, Electron Microscopy, Immunofluorescence, Liquid Chromatography with Mass Spectroscopy, Control